Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemiaSteven E. Lipshultz, Lewis B. Silverman, Stuart R. Lipsitz et al.|Cancer|2013Cited by 160
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M. Vrooman, Stephen E. Sallan, Donna Neuberg et al.|European Journal of Cancer|2011Cited by 117
A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphomaRebecca L. Johnston, Christian Steidl, Kara M. Kelly et al.|Blood|2021Cited by 17
Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma PatientsAnja Mottok, Christian Steidl, Rebecca L. Johnston et al.|Blood|2015Cited by 13
Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia ProtocolCharlene Rae, Ronald D. Barr, William Furlong et al.|Journal of Pediatric Hematology/Oncology|2018Cited by 7